1
|
Feng LS, Gao C, Liu FW, Wang XP, Zhang ZL. Recent updates on the anticancer activity of quinoxaline hybrids (Jan. 2017-Jan. 2022). Curr Top Med Chem 2022; 22:1426-1441. [DOI: 10.2174/1568026622666220428093955] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Revised: 02/18/2022] [Accepted: 02/18/2022] [Indexed: 11/22/2022]
Abstract
Abstract:
Cancer as one of the leading causes of death among non-communicable diseases has already posed a heavy burden on the world health system. Chemotherapy is one of the most effective approaches for cancer treatment, but multidrug resistance, lack of efficacy, and toxic side effects hamper efficacious cancer chemotherapy, creating an urgent need to develop novel, more effective and less toxic anticancer therapeutics. Quinoxalines as fascinating structures constitute an important class of heterocycles in drug discovery. Quinoxaline hybrids could exert anticancer activity through diverse mechanisms and possess profound in vitro and in vivo efficacy against various cancers including multidrug-resistant forms. Thus, quinoxaline hybrids represent useful templates for the control and eradication of cancer. The purpose of the present review article is to provide an emphasis on the recent developments (Jan. 2017-Jan. 2022) in quinoxaline hybrids with insights into their in vitro and in vivo anticancer potential as well as structure-activity relationships (SARs) to facilitate further rational design of more effective candidates.
Collapse
|
2
|
Karmakar R, Mukhopadhyay C. Synthesis of new horizons in benzothiazole scaffold and used in anticancer drug development. PHYSICAL SCIENCES REVIEWS 2022. [DOI: 10.1515/psr-2021-0044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Benzothiazole scaffolds exhibit exciting medicinal properties including anticancer. In recent time most complicated job for every researcher is to discover a novel drug that can treat cancer with minimal side effects. Some heterocyclic anticancer drugs including daunorubicin, 5-flourouracil, doxorubicin, methotrexate, etc. are markedly available. In addition, few natural products such as vincristine alongwith vinblastine are used as anticancer drugs. More than 90% of the novel drugs bearing heterocyclic moieties have always been main portions in the development of anticancer drugs. Heterocyclic compounds containing benzothiazole moiety show a superior pharmaceutical effect than non-nitrogen compounds. These N-/S-containing benzothiazole compounds, the heart of drug discovery, present a significant and valuable group of molecules that play a chief and vital role in our living cells. This chapter recites the weightage of benzothiazole nuclei in the progress of anticancer drugs.
Collapse
Affiliation(s)
- Rajiv Karmakar
- Department of Chemistry , University of Calcutta , 92 APC Road , Kolkata 700009 , India
- Department of Chemistry , Dum Dum Motijheel College, West Bengal State University , Kolkata 700074 , India
| | - Chhanda Mukhopadhyay
- Department of Chemistry , University of Calcutta , 92 APC Road , Kolkata 700009 , India
| |
Collapse
|
3
|
Abad N, Hajji M, Ramli Y, Belkhiria M, Moftah H. Elmgirhi S, A. Habib M, Guerfel T, T. Mague J, Essassi EM. A newly synthesized nitrogen‐rich derivative of bicyclic quinoxaline—Structural and conceptual DFT reactivity study. J PHYS ORG CHEM 2020. [DOI: 10.1002/poc.4055] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Nadeem Abad
- Laboratoire de Chimie Organique Hétérocyclique, Centre de Recherche des Sciences des médicaments, URAC 21, Pôle de Compétence Pharmacochimie, Av Ibn Battouta, bp 1014, Faculté des SciencesUniversité´ Mohammed V Rabat Morocco
| | - Melek Hajji
- Research Unit: Electrochemistry, Materials and EnvironmentUniversity of Kairouan Kairouan Tunisia
| | - Youssef Ramli
- Laboratory of Medicinal Chemistry, Faculty of Medicine and PharmacyMohammed V University Rabat Morocco
| | - Marwa Belkhiria
- Laboratoire de Chimie Hétérocyclique, Produits Naturels et Réactivité: L.C.H.P.N.RFaculté des Sciences de Monastir Monastir Tunisia
| | | | - Mohamed A. Habib
- Department of Chemistry, Faculty of EducationSirte University Sirte Libya
| | - Taha Guerfel
- Research Unit: Electrochemistry, Materials and EnvironmentUniversity of Kairouan Kairouan Tunisia
| | - Joel T. Mague
- Department of ChemistryTulane University New Orleans LA USA
| | - El Mokhtar Essassi
- Laboratoire de Chimie Organique Hétérocyclique, Centre de Recherche des Sciences des médicaments, URAC 21, Pôle de Compétence Pharmacochimie, Av Ibn Battouta, bp 1014, Faculté des SciencesUniversité´ Mohammed V Rabat Morocco
| |
Collapse
|